Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease.

Area of Science:

• Biochemistry
• Gastroenterology
• Nutritional Science

Background:

• Inflammatory bowel disease (IBD), encompassing ulcerative colitis and Crohn's disease, involves complex pathophysiological mechanisms.
• Fatty acids play crucial roles in cellular function, inflammation, and immune responses, making their profiles relevant to IBD pathogenesis.

Purpose of the Study:

• To investigate plasma fatty acid patterns in patients with active inflammatory bowel disease (IBD).
• To assess the influence of disease activity and severity on fatty acid profiles in IBD.
• To explore the implications of these findings for IBD pathogenesis and treatment.

Main Methods:

• Gas liquid chromatography was employed to analyze plasma fatty acid patterns.
• Seventy-three patients with active IBD (ulcerative colitis and Crohn's disease) and 107 healthy controls were included.
• Disease activity and severity were correlated with observed fatty acid profiles.

Main Results:

• Plasma fatty acid patterns were similar between ulcerative colitis and Crohn's disease patients.
• Active IBD patients exhibited significantly higher plasma C18:3n3 and C22:6n3 (n3 fatty acids) and lower C20:3n6 (n6 fatty acid) compared to controls.
• Increased disease severity was associated with a significant decrease in plasma polyunsaturated fatty acid concentrations and the desaturation index.

Conclusions:

• Active IBD may involve both increased biosynthesis and consumption of polyunsaturated fatty acids.
• Altered fatty acid profiles in IBD suggest a role in disease pathogenesis, impacting eicosanoid synthesis and immune cell function.
• The findings question the current rationale for using n3 polyunsaturated fatty acids as a therapeutic intervention in inflammatory bowel disease.